Association Between Availability of a Price Transparency Tool and Outpatient Spending
Autor: | Sunita Desai, Andrew L. Hicks, Ateev Mehrotra, Laura A. Hatfield, Michael E. Chernew |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
Male medicine.medical_specialty Adolescent Transparency (market) Community participation MEDLINE Disclosure 03 medical and health sciences 0302 clinical medicine Health care Outpatients medicine Humans 030212 general & internal medicine Cost Sharing Child business.industry 030503 health policy & services Community Participation Infant Newborn Infant General Medicine Health Care Costs Middle Aged Infant newborn United States Health Benefit Plans Employee Family medicine Child Preschool Cost sharing Female Health Expenditures 0305 other medical science business Delivery of Health Care |
Zdroj: | JAMA. 315(17) |
ISSN: | 1538-3598 |
Popis: | Importance There is increasing interest in using price transparency tools to decrease health care spending. Objective To measure the association between offering a health care price transparency tool and outpatient spending. Design, Setting, and Participants Two large employers represented in multiple market areas across the United States offered an online health care price transparency tool to their employees. One introduced it on April 1, 2011, and the other on January 1, 2012. The tool provided users information about what they would pay out of pocket for services from different physicians, hospitals, or other clinical sites. Using a matched difference-in-differences design, outpatient spending among employees offered the tool (n=148 655) was compared with that among employees from other companies not offered the tool (n=295 983) in the year before and after it was introduced. Exposure Availability of a price transparency tool. Main Outcomes and Measures Annual outpatient spending, outpatient out-of-pocket spending, use rates of the tool. Results Mean outpatient spending among employees offered the tool was $2021 in the year before the tool was introduced and $2233 in the year after. In comparison, among controls, mean outpatient spending changed from $1985 to $2138. After adjusting for demographic and health characteristics, being offered the tool was associated with a mean $59 (95% CI, $25-$93) increase in outpatient spending. Mean outpatient out-of-pocket spending among those offered the tool was $507 in the year before introduction of the tool and $555 in the year after. Among the comparison group, mean outpatient out-of-pocket spending changed from $490 to $520. Being offered the price transparency tool was associated with a mean $18 (95% CI, $12-$25) increase in out-of-pocket spending after adjusting for relevant factors. In the first 12 months, 10% of employees who were offered the tool used it at least once. Conclusions and Relevance Among employees at 2 large companies, offering a price transparency tool was not associated with lower health care spending. The tool was used by only a small percentage of eligible employees. |
Databáze: | OpenAIRE |
Externí odkaz: |